A new sulfonylurea called Amaryl (AM-a-ril, glimepiride)

March 1996

A new sulfonylurea called Amaryl (AM-a-ril, glimepiride) will soon hit the market. It's from Hoechst Marion Roussel...the same folks who market DiaBeta (glyburide).

Amaryl works as well as glyburide.

The company will claim that Amaryl causes less hypoglycemia. But the jury is still out on whether this is significant.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote